Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours
14 Apr 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours
Minimal residual disease in multiple myeloma
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Update on the new EUSOMA quality indicators for breast cancer
The optimal approach after neoadjuvant treatment: The Lucerne toolbox
Lung cancer in India
ecancer-AORTIC special issue on cancer research training in Africa
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
OncoAlert Colloquium Day 4: GI oncology and EONS
OncoAlert Colloquium Day 3: Breast cancer
OncoAlert Colloquium Day 2: Lung cancer and MASCC